fingolimod hydrochloride has been researched along with DDD MPGNII in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, AP; Huang, XD; Jiang, JY; Wang, Y; Zhou, JH | 1 |
| Budde, K; Daig, U; Krämer, S; Loof, T; Martini, S; Neumayer, HH; Peters, H; Wang-Rosenke, Y | 1 |
2 other study(ies) available for fingolimod hydrochloride and DDD MPGNII
| Article | Year |
|---|---|
[FTY720 attenuates rat anti-Thy-1 mesangial proliferative glomerulonephritis by inhibition of transforming growth factor β1-connective tissue growth factor pathway].
Topics: Animals; Cell Proliferation; Connective Tissue Growth Factor; Down-Regulation; Extracellular Matrix Proteins; Fingolimod Hydrochloride; Gene Expression; Glomerular Mesangium; Glomerulonephritis, Membranoproliferative; Immunosuppressive Agents; Isoantibodies; Kidney Glomerulus; Male; Propylene Glycols; Proteinuria; Rats; Rats, Wistar; Signal Transduction; Sphingosine; Thy-1 Antigens; Transforming Growth Factor beta1 | 2012 |
S1P modulator FTY720 limits matrix expansion in acute anti-thy1 mesangioproliferative glomerulonephritis.
Topics: Animals; Antibodies, Blocking; Blood Pressure; Body Weight; Collagen Type III; Extracellular Matrix; Fibronectins; Fingolimod Hydrochloride; Glomerulonephritis, Membranoproliferative; Heart Rate; Immunohistochemistry; Kidney Glomerulus; Leukocyte Count; Lipopolysaccharides; Male; Nitric Oxide Synthase Type II; Plasminogen Activator Inhibitor 1; Propylene Glycols; Proteinuria; Rats; Rats, Wistar; Receptors, Lysosphingolipid; Sphingosine; Thy-1 Antigens; Transforming Growth Factor beta | 2007 |